These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 3499211)

  • 41. [Treatment of a case of childhood acute non-lymphocytic leukemia (ANLL) using high-dose cytosine arabinoside for intensification of early therapy].
    Imashuku S; Nakajima T; Morimoto S; Hibi S; Todo S; Morioka Y; Sugimoto T
    Gan To Kagaku Ryoho; 1987 Feb; 14(2):527-30. PubMed ID: 3813580
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Advanced stage (III-IV) Burkitt's lymphoma and B-cell acute lymphoblastic leukaemia in children: kinetic and pharmacologic rationale for treatment and recent results (1979-1983).
    Murphy SB; Bowman WP; Hustu HO; Berard CW
    IARC Sci Publ; 1985; (60):405-18. PubMed ID: 3905592
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Results of treatment of advanced-stage Burkitt's lymphoma and B cell (SIg+) acute lymphoblastic leukemia with high-dose fractionated cyclophosphamide and coordinated high-dose methotrexate and cytarabine.
    Murphy SB; Bowman WP; Abromowitch M; Mirro J; Ochs J; Rivera G; Pui CH; Fairclough D; Berard CW
    J Clin Oncol; 1986 Dec; 4(12):1732-9. PubMed ID: 3491184
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Long-term results of 2 therapeutic protocols in children with acute lymphoblastic leukemia of usual risk. Experience at the 20th of November National Medical Center].
    López-Hernández MA; de Diego Flores-Chapa J; Borbolla-Escoboza JR; Trueba-Christy E; Carrillo-Rosales T; González-Avante M
    Gac Med Mex; 1998; 134(2):145-51. PubMed ID: 9618993
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intensive oral methotrexate protects against lymphoid marrow relapse in childhood B-precursor acute lymphoblastic leukemia.
    Winick N; Shuster JJ; Bowman WP; Borowitz M; Farrow A; Jacaruso D; Buchanan GR; Kamen BA
    J Clin Oncol; 1996 Oct; 14(10):2803-11. PubMed ID: 8874342
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effectiveness of rubidomycin in induction therapy with vincristine, prednisone, and L-asparaginase for standard risk childhood acute lymphocytic leukemia: results of a Dutch phase III study (ALL V). A report on behalf of the Dutch Childhood Leukemia Study Group (DCLSG).
    van der Does-van den Berg A; van Wering ER; Suciu S; Solbu G; van 't Veer MB; Rammeloo JA; de Koning J; van Zanen GE
    Am J Pediatr Hematol Oncol; 1989; 11(2):125-33. PubMed ID: 2665546
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of prednisolone, vincristine, methotrexate and 6-mercaptopurine vs. 6-mercaptopurine and prednisone maintenance therapy in childhood acute leukemia: a Southwest Oncology Group Study.
    Berry DH; Fernbach DJ; Herson J; Pullen J; Sullivan MP; Vietti TJ
    Cancer; 1980 Sep; 46(5):1098-1103. PubMed ID: 7011531
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment of adult lymphoblastic leukaemia using cyclical chemotherapy with three combinations of four drugs (COAP, POMP, TRAP schedule).
    Proctor SJ; Finney R; Walker W; Thompson RB
    Postgrad Med J; 1981 Jan; 57(663):19-22. PubMed ID: 6944694
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A randomized trial of induction therapy (daunorubicin, vincristine, prednisone versus daunorubicin, vincristine, prednisone, cytarabine and 6-thioguanine) in adult acute lymphoblastic leukemia with long-term follow-up: an Eastern Cooperative Oncology Group Study (E3486).
    Wiernik PH; Cassileth PA; Leong T; Hoagland HC; Bennett JM; Paietta E; Oken MM;
    Leuk Lymphoma; 2003 Sep; 44(9):1515-21. PubMed ID: 14565653
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cytokinetically based induction chemotherapy and splenectomy for childhood acute nonlymphocytic leukemia.
    Dahl GV; Kalwinsky DK; Murphy S; Look AT; Amadori S; Kumar M; Novak R; George SL; Mason C; Mauer AM; Simone JV
    Blood; 1982 Oct; 60(4):856-63. PubMed ID: 6896834
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Improved treatment results in boys with overt testicular relapse during or shortly after initial therapy for acute lymphoblastic leukemia. A Pediatric Oncology group study.
    Buchanan GR; Boyett JM; Pollock BH; Smith SD; Yanofsky RA; Ghim T; Wharam MD; Crist WM; Vietti TJ; Johnson W
    Cancer; 1991 Jul; 68(1):48-55. PubMed ID: 2049752
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Results of treatment of children with acute lymphatic leukemia (ALL) according to the ALL V protocol of the Netherlands Working Group on Leukemia in Children].
    van der Does-van den Berg A; van Wering ER; Suciu S; Solbu G; Rammeloo JA; de Koning J; van Zanen GE
    Tijdschr Kindergeneeskd; 1988 Apr; 56(2):61-6. PubMed ID: 3287685
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Improved disease-free survival of children with acute lymphoblastic leukemia at high risk for early relapse with the New York regimen--a new intensive therapy protocol: a report from the Childrens Cancer Study Group.
    Steinherz PG; Gaynon P; Miller DR; Reaman G; Bleyer A; Finklestein J; Evans RG; Meyers P; Steinherz LJ; Sather H
    J Clin Oncol; 1986 May; 4(5):744-52. PubMed ID: 3517244
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treatment of childhood acute lymphoblastic leukemia with protocol TCL821: a report of Taiwan Children's Cancer Study Group.
    Taiwan Yi Xue Hui Za Zhi; 1989 Jan; 88(1):48-56. PubMed ID: 2666568
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Consolidation therapy for childhood acute lymphoblastic leukaemia: clinical and cellular pharmacology of cytosine arabinoside, epipodophyllotoxins and cyclophosphamide.
    Estlin EJ; Yule SM; Lowis SP
    Cancer Treat Rev; 2001 Dec; 27(6):339-50. PubMed ID: 11908927
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intermediate and high-dose cytosine arabinoside-containing regimens for induction and consolidation therapy for patients with acute lymphoblastic leukemia and lymphoblastic non-Hodgkin's lymphoma: the Leyden experience and review of the literature.
    Peters WG; Willemze R; Colly LP
    Semin Oncol; 1987 Jun; 14(2 Suppl 1):86-91. PubMed ID: 3473687
    [No Abstract]   [Full Text] [Related]  

  • 57. [Advances in the treatment of acute myeloid leukemia in children. Experience of the Argentinian Group of Acute Leukemia Treatment and the Latin American Group of Malignant Hemopathies Treatment 1967-1987].
    Freigeiro D; Scaglione C; Santarelli MT; Sackmann Muriel F; Jiménez E; Pavlovsky S; Bustelo P; Richard L; Kohan R; Kvicala R
    Sangre (Barc); 1989 Jun; 34(3):221-8. PubMed ID: 2669186
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Poor outcome of intensive chemotherapy for adult acute lymphoblastic leukemia: a possible dose effect.
    Chiu EK; Chan LC; Liang R; Lie A; Kwong YL; Todd D; Chan TK
    Leukemia; 1994 Sep; 8(9):1469-73. PubMed ID: 8090027
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Results of the treatment of lymphoblastic leukemia by the BFM program in children--a 5-year observation].
    Rokicka-Milewska R; Derulska D; Makowska K; Skwarska E; Lewicki Z
    Acta Haematol Pol; 1987; 18(1-2):1-8. PubMed ID: 3481150
    [No Abstract]   [Full Text] [Related]  

  • 60. Teniposide (VM-26) and continuous infusion cytosine arabinoside for initial induction failure in childhood acute lymphoblastic leukemia. A Pediatric Oncology Group pilot study.
    Ochs J; Rivera GK; Pollock BH; Buchanan G; Crist W; Freeman AI
    Cancer; 1990 Oct; 66(8):1671-7. PubMed ID: 2208021
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.